Jim Simons Seagen Inc. Transaction History

Renaissance Technologies LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$191.51 - $216.16 $38.6 Million - $43.5 Million	-201,400 Reduced 23.74%	647,113 $137 Million
Q2 2023 Aug 11, 2023	BUY	$187.64 - $206.25 $157 Million - $173 Million	837,813 Added 7830.03%	848,513 $163 Million
Q1 2023 May 12, 2023	SELL	$127.59 - $203.08 $54.9 Million - $87.3 Million	-429,913 Reduced 97.57%	10,700 $2.17 Million
Q4 2022 Feb 13, 2023	BUY	$117.37 - $139.17 $24.4 Million - $28.9 Million	207,500 Added 89.01%	440,613 $56.6 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $27.6 Million - $36.7 Million	203,813 Added 695.61%	233,113 $31.9 Million

Q2 2022 Aug 12, 2022	SELL	$108.81 - $179.33 $1.49 Million - $2.46 Million	-13,700 Reduced 31.86%	29,300 $5.18 Million
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $143,532 - $189,420	-1,200 Reduced 2.71%	43,000 $6.19 Million
Q4 2021 Feb 11, 2022	SELL	$142.57 - $190.86 $13.4 Million - $17.9 Million	-93,900 Reduced 67.99%	44,200 $6.83 Million
Q3 2021 Nov 12, 2021	SELL	$142.45 - $169.82 $30.3 Million - $36.1 Million	-212,513 Reduced 60.61%	138,100 $23.4 Million
Q2 2021 Aug 13, 2021	SELL	$135.08 - $161.1 $55.5 Million - $66.1 Million	-410,500 Reduced 53.93%	350,613 $55.4 Million
Q1 2021 May 13, 2021	BUY	$137.51 - $190.8 $77 Million - $107 Million	559,800 Added 278.07%	761,113 $106 Million
Q4 2020 Feb 10, 2021	BUY	$164.63 - $211.93 $33.1 Million - $42.7 Million	201,313 New	201,313 $35.3 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.